However, whether their expression levels in these cells are higher than those in the normal bone marrow cells, and the specific NOTCH1 ligand that is involved in activating NOTCH1 signaling in CLL-HSCs, remain to be defined. The gene discussed is NOTCH1; the disease is B-cell chronic lymphocytic leukemia.